The National Community Pharmacists Association in collaboration with CPESN® USA and Bristol Myers Squibb today announced that a pioneering research project enlisting pharmacists and their teams to screen for signs of heart disease and stroke will be tripled in scope because of the dramatic results produced by the first phase. READ MORE HERE.